Universal Registration Document 2023

10.7 Cross reference table for the management report

10. Additional Information

10.7 Cross reference table for the management report

10.7 10.7 CROSS REFERENCE TABLE FOR THE MANAGEMENT REPORT

Comments on the financial year

not-included Page number Chapter
Situation and business activities of the Company and the Groupe 20 - 33 1.1 to 1.3
Business results of the Company and the Groupe

280 - 282;

358;

359 - 360;

376 - 377;

384

6.1 to 6.3;

7.1;

7.2;

7.4 (note 23);

7.5

Objective and exhaustive analysis of business developments, results andfinancial position of the Company and the Groupe

34 - 36;

266 - 277

1.4; 5.1 to 5.5
Key performance indicators of a financial and, as the case may be, non‑financial nature relating to the Company’s specific activity, including information on environmental and employee matters

 159 - 264;

268 - 274

4; 5.2 to 5.4
Key events occurring between the reporting date of the financial year and the date the report is prepared

38 - 45;

71,

94

2.1;

3.1.1.4; 3.1.3.4

Foreseeable development of the Company and the Groupe

36;

100 - 101

1.4.3; 3.2
Dividends distributed over the three preceding years and amount of income distributed during the same years eligible for 40% deduction 277 5.6
Investments or controlling interests in companies headquartered in French territory

25;

34 - 35 

1.2.2; 1.4.1

Presentation of the Groupe

not-included Page number Chapter
Description of the main risk factors and uncertainties faced by the Company and the Groupe 38 - 45

2.1

Indications of financial risks linked to the effects of climate change and presentation of measures taken to reduce them through implementation of a low carbon strategy

241;

167 to 185

248 to 249

4.3.10.2.3; 4.1; 4.4
Main features of internal control and risk management procedures relating to the preparation and processing of the accounting and financial information  46 - 49

2.2

Indications of objectives and policy regarding each main category using hedge accounting, and the exposure to risks relating to prices, credit, liquidity and cash flow (use of financial instruments by the Company)

38 - 45;

271 - 274;

287 - 295;

321 - 325;

329 - 332;

332 - 334

2.1; 5.4;

6.6

(notes 1.3, 24, 29, 30)
Declaration of non‑financial performance 159 - 264  4
Duty of Care Plan to identify risks and prevent serious infringements in the areas of human rights, fundamental freedoms, health, security and the environment, resulting from the activity of the Company and of the companies it controls and from the activities of subcontractors and suppliers 237 - 241

4.3.10

Research and development activities  36 ; 287 - 295 

1.6; 6.6

(note 1.3)
Existing branches not-included NA